Loading organizations...
§ Private Profile · Hangzhou, Zhejiang, China
CDMO offering comprehensive services for cell and gene therapy, including plasmids, viral vectors, and mRNA production.
CoJourney is a contract development and manufacturing organization providing end-to-end gene therapy production services, based dually in Philadelphia, Pennsylvania, and Hangzhou, China. The company specializes in process development, cGMP manufacturing, and analytical testing for plasmids, viral vectors, and mRNA products from research to commercial scale. Operating with a team of five employees, the firm utilizes proprietary platforms like the column-free Zero Chrom system to support global cell and gene therapy developers. CoJourney has secured $30 million in Series A financing backed by prominent institutional investors including Legend Capital, GL Ventures, and Lake Bleu Capital. The organization has successfully facilitated multiple Investigational New Drug approvals in both the United States and China for its various biotechnology clients. CoJourney was originally founded in 2021 by Lijun Wang alongside a team of scientists specializing in gene therapy commercialization.
CoJourney has raised $30.0M across 1 funding round.
CoJourney has raised $30.0M in total across 1 funding round.
CoJourney has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series A in July 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 13, 2023 | $30M Series A | Legend Capital | Lake Bleu Capital | Announced |
CoJourney has raised $30.0M in total across 1 funding round.
CoJourney's investors include Legend Capital, Lake Bleu Capital.